Cullin 3 anticorps
-
- Antigène Voir toutes Cullin 3 (CUL3) Anticorps
- Cullin 3 (CUL3)
-
Reactivité
- Humain
-
Hôte
- Chèvre
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cullin 3 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Séquence
- AQVTGSNTRK HILQ
- Purification
- Anti-Cullin 3 antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Isotype
- IgG
- Top Product
- Discover our top product CUL3 Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Concentration
- 0.5 mg/mL
- Buffer
- 0.5 mg/mL in Tris saline, with 0.5 % bovine serum albumin and 0.02 % sodium azide, pH 7.3 .
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Antigène
- Cullin 3 (CUL3)
- Autre désignation
- Cullin 3 (CUL3 Produits)
- Synonymes
- anticorps CUL-3, anticorps Cullin-3, anticorps CUL-3-A, anticorps Cullin-3-A, anticorps cul3, anticorps cul3a, anticorps CUL-3-B, anticorps Cullin-3-B, anticorps cul3b, anticorps wu:fc37e01, anticorps CUL3, anticorps ATCUL3, anticorps ATCUL3A, anticorps CUL3A, anticorps T24P13.25, anticorps cullin 3, anticorps cullin 3A, anticorps PHA2E, anticorps AI467304, anticorps AW146203, anticorps mKIAA0617, anticorps cullin 3, anticorps cullin 3 L homeolog, anticorps cullin 3 S homeolog, anticorps cullin-3, anticorps Cullin-3 (CUL-3), anticorps cullin 3a, anticorps CULlin, anticorps CUL3, anticorps cul3, anticorps cul3.L, anticorps cul3.S, anticorps PTRG_11586, anticorps Smp_117580, anticorps cul3a, anticorps Cul3, anticorps cul-3
- Sujet
- Goat polyclonal to Cullin 3.
- ID gène
- 8452
- UniProt
- Q13618
- Pathways
- M Phase
-